Patents by Inventor Qiangbai LI

Qiangbai LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10391123
    Abstract: The present invention provided an anticancer nano-silver composition for the treatment and prevention of cervical cancer. The composition contains nano-silver powder 3-200 mg/kg, carbomer 700-1000 mg/kg, triethanolamine 700-1000 mg/kg, glucose 2.8-3.2 g/kg, and water as remaining; of the nano-silver powder, wherein the purity of silver is ?99.99% and particle size is 1-5 nm. Experiments demonstrated that the anticancer nano-silver composition can be used to inhibit HeLa proliferation, and cause cell death. The anticancer nano-silver composition of the present invention can be used to manufacture medicaments for the treatment and prevention of cervical cancer.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: August 27, 2019
    Inventors: Jinjun Liu, Weiyi B. H. Situ, Qiangbai Li
  • Publication number: 20170266229
    Abstract: The present invention provided an anticancer nano-silver composition for the treatment and prevention of cervical cancer. The composition contains nano-silver powder 3-200 mg/kg, carbomer 700-1000 mg/kg, triethanolamine 700-1000 mg/kg, glucose 2.8-3.2 g/kg, and water as remaining; of the nano-silver powder, wherein the purity of silver is ?99.99% and particle size is 1-5 nm. Experiments demonstrated that the anticancer nano-silver composition can be used to inhibit HeLa proliferation, and cause cell death. The anticancer nano-silver composition of the present invention can be used to manufacture medicaments for the treatment and prevention of cervical cancer.
    Type: Application
    Filed: March 27, 2015
    Publication date: September 21, 2017
    Applicant: CHANGSHA DIGU NANO BIOTECHNOLOGY CO., LTD.
    Inventors: Jinjun Liu, Weiyi B.H. Situ, Qiangbai Li
  • Publication number: 20170119818
    Abstract: The present invention provided an anticancer nano-silver composition for the treatment of lung cancer. The composition contains spherical nano-silver powder 12-200 mg/kg, pharmaceutically acceptable dispersing agent carbomer 700-800 mg/kg, triethanolamine 700-800 mg/kg, glucose 2.8-3.2 g/kg, and purified water as the diluent; of the spherical nano-silver powder, the purity of silver is ?99.99% and the particle size is 1-5 nm. Experiments demonstrated that the anticancer nano-silver composition can be used to inhibit proliferation of the human non-small cell lung cancer A549, and cause all cells death. The nano-silver composition of the present invention can be used in the manufacture of medicaments and for the treatment of lung cancer.
    Type: Application
    Filed: May 8, 2015
    Publication date: May 4, 2017
    Applicant: CHANGSHA DIGU NANO BIOTECHNOLOGY CO., LTD.
    Inventors: Jinjun LIU, Weiyi SITU, Qiangbai LI